Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

Stopped early · Phase 1/Phase 2

Conditions studied: Advanced Cancer, Pancreatic Cancer, Renal Cell Cancer, Non Small Cell Lung Cancer, Colorectal Carcinoma, Endometrial, Uterine

In brief

Determine Phase 2 dose of study drug

Key facts

Study ID

NCT02423954

Run by

Western Regional Medical Center

People needed

33

Starts

2015-04-01

Expected to finish

2017-11-01

Last updated by the study team

2018-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cancer Treatment Center of America @ Western Regional Medical Center — Goodyear, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.